norcantharidin has been researched along with Carcinoma, Anaplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, AW; Chen, MK; Chuang, YC; Hsi, YT; Hsieh, MJ; Lin, CC; Lin, SH; Lo, YS; Tseng, YS; Yu, CY | 1 |
| Chen, CQ; Fan, YZ; Fu, JY; Sun, W; Zhao, ZM | 1 |
| Chen, CQ; Fan, YZ; Fu, JY; Zhao, ZM | 1 |
3 other study(ies) available for norcantharidin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Norcantharidin induce apoptosis in human nasopharyngeal carcinoma through caspase and mitochondrial pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Humans; Mitochondria; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2018 |
Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatin; Cyclin D1; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gallbladder Neoplasms; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Time Factors; Xenograft Model Antitumor Assays | 2010 |
Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Carcinoma; Cell Line, Tumor; Cell Proliferation; Gallbladder Neoplasms; Humans; Immunohistochemistry; Ki-67 Antigen; Proliferating Cell Nuclear Antigen; Staining and Labeling | 2004 |